{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:07:50Z","timestamp":1767182870175,"version":"build-2238731810"},"reference-count":21,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,1,1]]},"DOI":"10.1542\/pir.18.1.10","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T20:49:03Z","timestamp":1639169343000},"page":"10-16","source":"Crossref","is-referenced-by-count":32,"title":["Guillain-Barre\u0301 Syndrome"],"prefix":"10.1542","volume":"18","author":[{"given":"Owen B.","family":"Evans","sequence":"first","affiliation":[{"name":"Professor and Chairman."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vettaikorumakankav","family":"Vedanarayanan","sequence":"additional","affiliation":[{"name":"Associate Professor, Department of Pediatrics, University of Mississippi Medical Center, Jackson, MS."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[1997,1,1]]},"reference":[{"key":"2021121013071716100_R1","doi-asserted-by":"crossref","unstructured":"Al-Qudah AA. Immunoglobulins in the treatment of Guillain-Barre\u0301 syndrome in early childhood. J Child Neurol.\u2008\u20081994;9:178-180","DOI":"10.1177\/088307389400900215"},{"key":"2021121013071716100_R2","doi-asserted-by":"crossref","unstructured":"Asbury AK. Diagnostic considerations in Guillain-Barre\u0301 syndrome. Ann Neurol.\u2008\u20081981;9(suppl):1-5","DOI":"10.1002\/ana.410090703"},{"key":"2021121013071716100_R3","doi-asserted-by":"crossref","unstructured":"Bradshaw DY, Jones HR. Guillain-Barre\u0301syndrome in children: clinical course,electrodiagnosis, and prognosis. Muscle Nerve.\u2008\u20081992;15:500-506","DOI":"10.1002\/mus.880150415"},{"key":"2021121013071716100_R4","doi-asserted-by":"crossref","unstructured":"Evans OB. Guillain-Barre\u0301 syndrome in childhood. Pediatr Rev.\u2008\u20081986;8:69-74","DOI":"10.1542\/pir.8-3-69"},{"key":"2021121013071716100_R5","doi-asserted-by":"crossref","unstructured":"Evans OB. Polyneuropathy in children. Pediatrics.\u2008\u20081979;64:96-105","DOI":"10.1542\/peds.64.1.96"},{"key":"2021121013071716100_R6","doi-asserted-by":"crossref","unstructured":"Farkkila M, Kinnunen E, Weckstrom P. Survey of Guillain-Barre\u0301 syndrome in southern Finland. Neuroepidemiology.\u2008\u20081991;10:236-241","DOI":"10.1159\/000110278"},{"key":"2021121013071716100_R7","doi-asserted-by":"crossref","unstructured":"Guillain-Barre\u0301 Syndrome Study Group. Plasmapheresis and acute Guillain-Barre\u0301 syndrome. Neurology.\u2008\u20081985;35:1096-1104","DOI":"10.1212\/WNL.35.8.1096"},{"key":"2021121013071716100_R8","doi-asserted-by":"crossref","unstructured":"Hart DE, Rojas LA, Rosario JA, et al. Childhood Guillain-Barre\u0301 syndrome in Paraguay,1990 to 1991. Ann Neurol.\u2008\u20081994;36:859-863","DOI":"10.1002\/ana.410360609"},{"key":"2021121013071716100_R9","doi-asserted-by":"crossref","unstructured":"Irani DN, Cornblath DR, Chaudhry V, et al. Relapse in Guillain-Barre\u0301 syndrome after treatment with human immune globulin. Neurology.\u2008\u20081993;43:857-858","DOI":"10.1212\/WNL.43.5.872"},{"key":"2021121013071716100_R10","doi-asserted-by":"crossref","unstructured":"Jansen PW, Perkin RM, Ashwal S. Guillain-Barre\u0301 syndrome in childhood: natural course and efficacy of plasmapheresis. Pediatr Neurol.\u2008\u20081993;9:16-20","DOI":"10.1016\/0887-8994(93)90004-V"},{"key":"2021121013071716100_R11","doi-asserted-by":"crossref","unstructured":"Kleyweg RP, van der Meche FG. Treatment-related fluctuations in Guillain-Barre\u0301syndrome after high-dose immunoglobulins or plasma-exchange. J Neurol Neurosurg Psychiatry.\u2008\u20081991;54:957-960","DOI":"10.1136\/jnnp.54.11.957"},{"key":"2021121013071716100_R12","doi-asserted-by":"crossref","unstructured":"Lamont PJ, Johnston HM, Berdoukas VA. Plasmapheresis in children with Guillain-Barre\u0301 syndrome. Neurology.\u2008\u20081991;41:1928-1931","DOI":"10.1212\/WNL.41.12.1928"},{"key":"2021121013071716100_R13","doi-asserted-by":"crossref","unstructured":"McLean M, Duclos P, Jacob P, Humphreys P. Incidence of Guillain-Barre\u0301 syndrome in Ontario and Quebec, 1983\u20131989, using hospital service databases. Epidemiology.\u2008\u20081994;5:443-448","DOI":"10.1097\/00001648-199407000-00011"},{"key":"2021121013071716100_R14","doi-asserted-by":"crossref","unstructured":"Plasma exchange in Guillain-Barre\u0301 syndrome:one-year follow-up. French Cooperative Group on Plasma Exchange in Guillain-Barre\u0301 Syndrome. Ann Neurol.\u2008\u20081992;32:94-97","DOI":"10.1002\/ana.410320115"},{"key":"2021121013071716100_R15","doi-asserted-by":"crossref","unstructured":"Rantala H, Uhari M, Niemela M. Occurrence,clinical manifestations, and prognosis of Guillain-Barre\u0301 syndrome. Arch Dis Child.\u2008\u20081991;66:706-708","DOI":"10.1136\/adc.66.6.706"},{"key":"2021121013071716100_R16","doi-asserted-by":"crossref","unstructured":"Rees JH, Soudain SE, Gregson NA, Hughes RAC. Campylobacter jejuni infection and Guillain-Barre\u0301 syndrome. N Engl J Med.\u2008\u20081995;333:1374-1379","DOI":"10.1056\/NEJM199511233332102"},{"key":"2021121013071716100_R17","doi-asserted-by":"crossref","unstructured":"Reisin RC, Cersosimo R, Garcia AM, et al. Acute axonal Guillain-Barre\u0301 syndrome in childhood. Muscle Nerve\u2008\u20081993;16:1310-1316","DOI":"10.1002\/mus.880161207"},{"key":"2021121013071716100_R18","doi-asserted-by":"crossref","unstructured":"Ruiz JC, Berciano J, Polo JM, et al. Treatment of Guillain-Barre\u0301 syndrome with protein-A immunoabsorption: report of two cases (letter). Ann Neurol.\u2008\u20081992;31:574-575","DOI":"10.1002\/ana.410310522"},{"key":"2021121013071716100_R19","doi-asserted-by":"crossref","unstructured":"Vajsar J, Sloane A, Wood E, Murphy EG. Plasmapheresis vs intravenous immunoglobulin treatment in childhood Guillain-Barre\u0301syndrome. Arch Pediatr Adolesc Med.\u2008\u20081994;148:1210-1212","DOI":"10.1001\/archpedi.1994.02170110096019"},{"key":"2021121013071716100_R20","doi-asserted-by":"crossref","unstructured":"Vallee L, Dulac O, Nuyts JP, et al. Intravenous immune globulin is also an efficient therapy of acute Guillain-Barre\u0301 syndrome in affected children. Neuropediatrics.\u2008\u20081993;24:235-236","DOI":"10.1055\/s-2008-1071548"},{"key":"2021121013071716100_R21","doi-asserted-by":"crossref","unstructured":"Yoshida M, Kuroki S, Mizue H. Plasmapheresis in the treatment of the Guillain-Barre\u0301syndrome in childhood. Pediatr Neurol.\u2008\u20081985;1:329-334","DOI":"10.1016\/0887-8994(85)90066-9"}],"container-title":["Pediatrics In Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article-pdf\/18\/1\/10\/988384\/pir10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article-pdf\/18\/1\/10\/988384\/pir10.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T09:31:15Z","timestamp":1640079075000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article\/18\/1\/10\/36690\/Guillain-Barre-Syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1,1]]},"references-count":21,"aliases":["10.1542\/pir.18-1-10"],"journal-issue":{"issue":"1","published-online":{"date-parts":[[1997,1,1]]},"published-print":{"date-parts":[[1997,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/pir.18.1.10","relation":{},"ISSN":["0191-9601","1526-3347"],"issn-type":[{"value":"0191-9601","type":"print"},{"value":"1526-3347","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,1,1]]}}}